{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:36:41Z","timestamp":1792798601843,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG078110"],"award-info":[{"award-number":["T32AG078110"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F31NS116912"],"award-info":[{"award-number":["F31NS116912"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kentucky Spinal and Head Injury Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuroinflammation contributes to secondary injury cascades following traumatic brain injury (TBI), with alternating waves of inflammation and resolution. Interleukin-1 (IL-1), a critical neuroinflammatory mediator originating from brain endothelial cells, microglia, astrocytes, and peripheral immune cells, is acutely overexpressed after TBI, propagating secondary injury and tissue damage. IL-1 affects blood\u2013brain barrier permeability, immune cell activation, and neural plasticity. Despite the complexity of cytokine signaling post-TBI, we hypothesize that IL-1 signaling specifically regulates neuroinflammatory response components. Using a closed-head injury (CHI) TBI model, we investigated IL-1's role in the neuroinflammatory cascade with a new global knock-out (gKO) mouse model of the IL-1 receptor (IL-1R1), which efficiently eliminates all IL-1 signaling. We found that IL-1R1 gKO attenuated behavioral impairments 14\u00a0weeks post-injury and reduced reactive microglia and astrocyte staining in the neocortex, corpus callosum, and hippocampus. We then examined whether IL-1R1 loss altered acute neuroinflammatory dynamics, measuring gene expression changes in the neocortex at 3, 9, 24, and 72\u00a0h post-CHI using the NanoString Neuroinflammatory panel. Of 757 analyzed genes, IL-1R1 signaling showed temporal specificity in neuroinflammatory gene regulation, with major effects at 9\u00a0h post-CHI. IL-1R1 signaling specifically affected astrocyte-related genes, selectively upregulating chemokines like Ccl2, Ccl3, and Ccl4, while having limited impact on cytokine regulation, such as Tnf\u03b1. This study provides further insight into IL-1R1 function in amplifying the neuroinflammatory cascade following CHI in mice and demonstrates that suppression of IL-1R1 signaling offers long-term protective effects on brain health.<\/jats:p>","DOI":"10.1186\/s12974-023-02934-3","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T02:02:48Z","timestamp":1698285768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["IL-1R1 signaling in TBI: assessing chronic impacts and neuroinflammatory dynamics in a mouse model of mild closed-head injury"],"prefix":"10.1186","volume":"20","author":[{"given":"Jonathan C.","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen N.","family":"Garnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Macheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly N.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K.","family":"Shahidehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Blalock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Bachstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"2934_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11481-011-9331-2","volume":"7","author":"SB Matousek","year":"2012","unstructured":"Matousek SB, Ghosh S, Shaftel SS, Kyrkanides S, Olschowka JA, O\u2019Banion MK. Chronic IL-1beta-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer\u2019s disease without inducing overt neurodegeneration. J Neuroimmune Pharmacol. 2012;7:156\u201364.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2934_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13311-014-0319-5","volume":"12","author":"AI Faden","year":"2015","unstructured":"Faden AI, Loane DJ. Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation? Neurotherapeutics. 2015;12:143\u201350.","journal-title":"Neurotherapeutics"},{"key":"2934_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrneurol.2013.29","volume":"9","author":"DH Smith","year":"2013","unstructured":"Smith DH, Johnson VE, Stewart W. Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol. 2013;9:211\u201321.","journal-title":"Nat Rev Neurol"},{"key":"2934_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","volume":"95","author":"YN Jassam","year":"2017","unstructured":"Jassam YN, Izzy S, Whalen M, McGavern DB, El Khoury J. Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron. 2017;95:1246\u201365.","journal-title":"Neuron"},{"key":"2934_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41423-019-0213-5","volume":"16","author":"K Shi","year":"2019","unstructured":"Shi K, Zhang J, Dong JF, Shi FD. Dissemination of brain inflammation in traumatic brain injury. Cell Mol Immunol. 2019;16:523\u201330.","journal-title":"Cell Mol Immunol"},{"key":"2934_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12974-020-02005-x","volume":"17","author":"A Alam","year":"2020","unstructured":"Alam A, Thelin EP, Tajsic T, Khan DZ, Khellaf A, Patani R, Helmy A. Cellular infiltration in traumatic brain injury. J Neuroinflamm. 2020;17:328.","journal-title":"J Neuroinflamm"},{"key":"2934_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon DW, McGeachy MJ, Bayir H, Clark RS, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13:171\u201391.","journal-title":"Nat Rev Neurol"},{"key":"2934_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633\u201352.","journal-title":"Nat Rev Drug Discov"},{"key":"2934_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fneur.2018.00008","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Quan N. Microglia and CNS interleukin-1: beyond immunological concepts. Front Neurol. 2018;9:8.","journal-title":"Front Neurol"},{"key":"2934_CR10","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41380-020-0788-3","volume":"26","author":"DJ DiSabato","year":"2021","unstructured":"DiSabato DJ, Nemeth DP, Liu X, Witcher KG, O\u2019Neil SM, Oliver B, Bray CE, Sheridan JF, Godbout JP, Quan N. Interleukin-1 receptor on hippocampal neurons drives social withdrawal and cognitive deficits after chronic social stress. Mol Psychiatry. 2021;26:4770\u201382.","journal-title":"Mol Psychiatry"},{"key":"2934_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hipo.10164","volume":"14","author":"AM Depino","year":"2004","unstructured":"Depino AM, Alonso M, Ferrari C, del Rey A, Anthony D, Besedovsky H, Medina JH, Pitossi F. Learning modulation by endogenous hippocampal IL-1: blockade of endogenous IL-1 facilitates memory formation. Hippocampus. 2004;14:526\u201335.","journal-title":"Hippocampus"},{"key":"2934_CR12","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.2174\/138161208786549281","volume":"14","author":"JM Krueger","year":"2008","unstructured":"Krueger JM. The role of cytokines in sleep regulation. Curr Pharm Des. 2008;14:3408\u201316.","journal-title":"Curr Pharm Des"},{"key":"2934_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12974-015-0289-5","volume":"12","author":"AD Bachstetter","year":"2015","unstructured":"Bachstetter AD, Webster SJ, Goulding DS, Morton JE, Watterson DM, Van Eldik LJ. Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic. J Neuroinflamm. 2015;12:69.","journal-title":"J Neuroinflamm"},{"key":"2934_CR14","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1523\/JNEUROSCI.3199-14.2015","volume":"35","author":"X Liu","year":"2015","unstructured":"Liu X, Yamashita T, Chen Q, Belevych N, McKim DB, Tarr AJ, Coppola V, Nath N, Nemeth DP, Syed ZW, et al. Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell types. J Neurosci. 2015;35:2860\u201370.","journal-title":"J Neurosci"},{"key":"2934_CR15","doi-asserted-by":"publisher","first-page":"10476","DOI":"10.1523\/JNEUROSCI.3357-07.2007","volume":"27","author":"S Ching","year":"2007","unstructured":"Ching S, Zhang H, Belevych N, He L, Lai W, Pu XA, Jaeger LB, Chen Q, Quan N. Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J Neurosci. 2007;27:10476\u201386.","journal-title":"J Neurosci"},{"key":"2934_CR16","first-page":"11","volume":"2011","author":"Y An","year":"2011","unstructured":"An Y, Chen Q, Quan N. Interleukin-1 exerts distinct actions on different cell types of the brain in vitro. J Inflamm Res. 2011;2011:11\u201320.","journal-title":"J Inflamm Res"},{"key":"2934_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.688254","volume":"12","author":"CN Bodnar","year":"2021","unstructured":"Bodnar CN, Watson JB, Higgins EK, Quan N, Bachstetter AD. Inflammatory regulation of CNS barriers after traumatic brain injury: a tale directed by interleukin-1. Front Immunol. 2021;12: 688254.","journal-title":"Front Immunol"},{"key":"2934_CR18","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.1073\/pnas.1205207109","volume":"109","author":"J Qian","year":"2012","unstructured":"Qian J, Zhu L, Li Q, Belevych N, Chen Q, Zhao F, Herness S, Quan N. Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase. Proc Natl Acad Sci U S A. 2012;109:12189\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2934_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0006-8993(94)01343-G","volume":"671","author":"S Toulmond","year":"1995","unstructured":"Toulmond S, Rothwell NJ. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res. 1995;671:261\u20136.","journal-title":"Brain Res"},{"key":"2934_CR20","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/00004647-199910000-00008","volume":"19","author":"KL Sanderson","year":"1999","unstructured":"Sanderson KL, Raghupathi R, Saatman KE, Martin D, Miller G, McIntosh TK. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury. J Cereb Blood Flow Metab. 1999;19:1118\u201325.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2934_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(00)01263-5","volume":"289","author":"SM Knoblach","year":"2000","unstructured":"Knoblach SM, Faden AI. Cortical interleukin-1 beta elevation after traumatic brain injury in the rat: no effect of two selective antagonists on motor recovery. Neurosci Lett. 2000;289:5\u20138.","journal-title":"Neurosci Lett"},{"key":"2934_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1460-9568.2005.04221.x","volume":"22","author":"NC Jones","year":"2005","unstructured":"Jones NC, Prior MJ, Burden-Teh E, Marsden CA, Morris PG, Murphy S. Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes. Eur J Neurosci. 2005;22:72\u20138.","journal-title":"Eur J Neurosci"},{"key":"2934_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neulet.2005.05.057","volume":"386","author":"KT Lu","year":"2005","unstructured":"Lu KT, Wang YW, Wo YY, Yang YL. Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci Lett. 2005;386:40\u20135.","journal-title":"Neurosci Lett"},{"key":"2934_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1460-9568.2009.06820.x","volume":"30","author":"F Clausen","year":"2009","unstructured":"Clausen F, Hanell A, Bjork M, Hillered L, Mir AK, Gram H, Marklund N. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci. 2009;30:385\u201396.","journal-title":"Eur J Neurosci"},{"key":"2934_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1460-9568.2011.07723.x","volume":"34","author":"F Clausen","year":"2011","unstructured":"Clausen F, Hanell A, Israelsson C, Hedin J, Ebendal T, Mir AK, Gram H, Marklund N. Neutralization of interleukin-1beta reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur J Neurosci. 2011;34:110\u201323.","journal-title":"Eur J Neurosci"},{"key":"2934_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fphar.2013.00129","volume":"4","author":"GD Anderson","year":"2013","unstructured":"Anderson GD, Peterson TC, Vonder Haar C, Kantor ED, Farin FM, Bammler TK, Macdonald JW, Hoane MR. Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model. Front Pharmacol. 2013;4:129.","journal-title":"Front Pharmacol"},{"key":"2934_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1208\/s12248-015-9792-y","volume":"17","author":"GD Anderson","year":"2015","unstructured":"Anderson GD, Peterson TC, Vonder Haar C, Farin FM, Bammler TK, MacDonald JW, Kantor ED, Hoane MR. Effect of traumatic brain injury, erythropoietin, and anakinra on hepatic metabolizing enzymes and transporters in an experimental rat model. AAPS J. 2015;17:1255\u201367.","journal-title":"AAPS J"},{"key":"2934_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jnr.23617","volume":"94","author":"JR Perez-Polo","year":"2016","unstructured":"Perez-Polo JR, Rea HC, Johnson KM, Parsley MA, Unabia GC, Xu GY, Prough D, DeWitt DS, Paulucci-Holthauzen AA, Werrbach-Perez K, Hulsebosch CE. Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury. J Neurosci Res. 2016;94:27\u201338.","journal-title":"J Neurosci Res"},{"key":"2934_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbi.2017.08.005","volume":"66","author":"M Sun","year":"2017","unstructured":"Sun M, Brady RD, Wright DK, Kim HA, Zhang SR, Sobey CG, Johnstone MR, O\u2019Brien TJ, Semple BD, McDonald SJ, Shultz SR. Treatment with an interleukin-1 receptor antagonist mitigates neuroinflammation and brain damage after polytrauma. Brain Behav Immun. 2017;66:359\u201371.","journal-title":"Brain Behav Immun"},{"key":"2934_CR30","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.1523\/JNEUROSCI.0982-17.2017","volume":"37","author":"BD Semple","year":"2017","unstructured":"Semple BD, O\u2019Brien TJ, Gimlin K, Wright DK, Kim SE, Casillas-Espinosa PM, Webster KM, Petrou S, Noble-Haeusslein LJ. Interleukin-1 receptor in seizure susceptibility after traumatic injury to the pediatric brain. J Neurosci. 2017;37:7864\u201377.","journal-title":"J Neurosci"},{"key":"2934_CR31","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0385-17.2018","author":"EA Newell","year":"2018","unstructured":"Newell EA, Todd BP, Mahoney J, Pieper AA, Ferguson PJ, Bassuk AG. Combined blockade of interleukin-1alpha and -1beta signaling protects mice from cognitive dysfunction after traumatic brain injury. eNeuro. 2018. https:\/\/doi.org\/10.1523\/ENEURO.0385-17.2018.","journal-title":"eNeuro"},{"key":"2934_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1089\/neu.2018.5659","volume":"36","author":"JY Chung","year":"2019","unstructured":"Chung JY, Krapp N, Wu L, Lule S, McAllister LM, Edmiston WJ 3rd, Martin S, Levy E, Songtachalert T, Sherwood JS, et al. Interleukin-1 receptor 1 deletion in focal and diffuse experimental traumatic brain injury in mice. J Neurotrauma. 2019;36:370\u20139.","journal-title":"J Neurotrauma"},{"key":"2934_CR33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1089\/neu.2019.6725","volume":"37","author":"LP Evans","year":"2020","unstructured":"Evans LP, Woll AW, Wu S, Todd BP, Hehr N, Hedberg-Buenz A, Anderson MG, Newell EA, Ferguson PJ, Mahajan VB, et al. Modulation of post-traumatic immune response using the IL-1 receptor antagonist anakinra for improved visual outcomes. J Neurotrauma. 2020;37:1463\u201380.","journal-title":"J Neurotrauma"},{"key":"2934_CR34","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1523\/JNEUROSCI.0682-21.2021","volume":"42","author":"L Wu","year":"2022","unstructured":"Wu L, Kalish BT, Finander B, Cao T, Jin G, Yahya T, Levy ES, Kukreja B, LaRovere ES, Chung JY, et al. Repetitive mild closed head injury in adolescent mice is associated with impaired proteostasis, neuroinflammation, and tauopathy. J Neurosci. 2022;42:2418\u201332.","journal-title":"J Neurosci"},{"key":"2934_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2020.108831","volume":"343","author":"T Macheda","year":"2020","unstructured":"Macheda T, Snider HC, Watson JB, Roberts KN, Bachstetter AD. An active avoidance behavioral paradigm for use in a mild closed head model of traumatic brain injury in mice. J Neurosci Methods. 2020;343: 108831.","journal-title":"J Neurosci Methods"},{"key":"2934_CR36","doi-asserted-by":"publisher","DOI":"10.3791\/64556-v","author":"T Macheda","year":"2022","unstructured":"Macheda T, Roberts K, Bachstetter AD. Electromagnetic controlled closed-head model of mild traumatic brain injury in mice. J Vis Exp. 2022. https:\/\/doi.org\/10.3791\/64556-v.","journal-title":"J Vis Exp"},{"key":"2934_CR37","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2337\/db05-1304","volume":"55","author":"MC Garcia","year":"2006","unstructured":"Garcia MC, Wernstedt I, Berndtsson A, Enge M, Bell M, Hultgren O, Horn M, Ahren B, Enerback S, Ohlsson C, et al. Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes. 2006;55:1205\u201313.","journal-title":"Diabetes"},{"key":"2934_CR38","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32:6391\u2013410.","journal-title":"J Neurosci"},{"key":"2934_CR39","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.4049\/jimmunol.1301637","volume":"191","author":"E Jang","year":"2013","unstructured":"Jang E, Kim JH, Lee S, Kim JH, Seo JW, Jin M, Lee MG, Jang IS, Lee WH, Suk K. Phenotypic polarization of activated astrocytes: the critical role of lipocalin-2 in the classical inflammatory activation of astrocytes. J Immunol. 2013;191:5204\u201319.","journal-title":"J Immunol"},{"key":"2934_CR40","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/jcbfm.2014.83","volume":"34","author":"M Jin","year":"2014","unstructured":"Jin M, Kim JH, Jang E, Lee YM, Soo Han H, Woo DK, Park DH, Kook H, Suk K. Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab. 2014;34:1306\u201314.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2934_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"CM Niswender","year":"2010","unstructured":"Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010;50:295\u2013322.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"Suppl 1","key":"2934_CR42","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/j.expneurol.2003.08.001","volume":"184","author":"AB Spillson","year":"2003","unstructured":"Spillson AB, Russell JW. Metabotropic glutamate receptor regulation of neuronal cell death. Exp Neurol. 2003;184(Suppl 1):S97-105.","journal-title":"Exp Neurol"},{"key":"2934_CR43","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/brain\/awab207","volume":"144","author":"F Mermer","year":"2021","unstructured":"Mermer F, Poliquin S, Rigsby K, Rastogi A, Shen W, Romero-Morales A, Nwosu G, McGrath P, Demerast S, Aoto J, et al. Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons. Brain. 2021;144:2499\u2013512.","journal-title":"Brain"},{"key":"2934_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100143","volume":"9","author":"M Criado-Marrero","year":"2020","unstructured":"Criado-Marrero M, Smith TM, Gould LA, Kim S, Penny HJ, Sun Z, Gulick D, Dickey CA, Blair LJ. FKBP5 and early life stress affect the hippocampus by an age-dependent mechanism. Brain Behav Immun Health. 2020;9: 100143.","journal-title":"Brain Behav Immun Health"},{"key":"2934_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fneur.2013.00018","volume":"4","author":"T Woodcock","year":"2013","unstructured":"Woodcock T, Morganti-Kossmann MC. The role of markers of inflammation in traumatic brain injury. Front Neurol. 2013;4:18.","journal-title":"Front Neurol"},{"key":"2934_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neubiorev.2021.11.036","volume":"132","author":"K Visser","year":"2022","unstructured":"Visser K, Koggel M, Blaauw J, van der Horn HJ, Jacobs B, van der Naalt J. Blood-based biomarkers of inflammation in mild traumatic brain injury: a systematic review. Neurosci Biobehav Rev. 2022;132:154\u201368.","journal-title":"Neurosci Biobehav Rev"},{"key":"2934_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fnbeh.2019.00287","volume":"13","author":"JG Thome","year":"2019","unstructured":"Thome JG, Reeder EL, Collins SM, Gopalan P, Robson MJ. Contributions of interleukin-1 receptor signaling in traumatic brain injury. Front Behav Neurosci. 2019;13:287.","journal-title":"Front Behav Neurosci"},{"key":"2934_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/BPL-200109","volume":"7","author":"DP Nemeth","year":"2021","unstructured":"Nemeth DP, Quan N. Modulation of neural networks by interleukin-1. Brain Plast. 2021;7:17\u201332.","journal-title":"Brain Plast"},{"key":"2934_CR49","doi-asserted-by":"publisher","first-page":"239821282097980","DOI":"10.1177\/2398212820979802","volume":"4","author":"JM Bourgognon","year":"2020","unstructured":"Bourgognon JM, Cavanagh J. The role of cytokines in modulating learning and memory and brain plasticity. Brain Neurosci Adv. 2020;4:2398212820979802.","journal-title":"Brain Neurosci Adv"},{"key":"2934_CR50","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.4103\/1673-5374.238604","volume":"13","author":"CN Bodnar","year":"2018","unstructured":"Bodnar CN, Morganti JM, Bachstetter AD. Depression following a traumatic brain injury: uncovering cytokine dysregulation as a pathogenic mechanism. Neural Regen Res. 2018;13:1693\u2013704.","journal-title":"Neural Regen Res"},{"key":"2934_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12264-010-6023-5","volume":"26","author":"ZB Huang","year":"2010","unstructured":"Huang ZB, Sheng GQ. Interleukin-1beta with learning and memory. Neurosci Bull. 2010;26:455\u201368.","journal-title":"Neurosci Bull"},{"key":"2934_CR52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191430","author":"B Mailhot","year":"2020","unstructured":"Mailhot B, Christin M, Tessandier N, Sotoudeh C, Bretheau F, Turmel R, Pellerin E, Wang F, Bories C, Joly-Beauparlant C, et al. Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20191430.","journal-title":"J Exp Med"},{"key":"2934_CR53","doi-asserted-by":"publisher","first-page":"12533","DOI":"10.1523\/JNEUROSCI.2840-11.2011","volume":"31","author":"S Nadeau","year":"2011","unstructured":"Nadeau S, Filali M, Zhang J, Kerr BJ, Rivest S, Soulet D, Iwakura Y, de Rivero Vaccari JP, Keane RW, Lacroix S. Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1beta and TNF: implications for neuropathic pain. J Neurosci. 2011;31:12533\u201342.","journal-title":"J Neurosci"},{"key":"2934_CR54","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2147\/JIR.S350114","volume":"15","author":"DP Nemeth","year":"2022","unstructured":"Nemeth DP, Liu X, McKim DB, DiSabato DJ, Oliver B, Herd A, Katta A, Negray CE, Floyd J, McGovern S, et al. Dynamic interleukin-1 receptor type 1 signaling mediates microglia-vasculature interactions following repeated systemic LPS. J Inflamm Res. 2022;15:1575\u201390.","journal-title":"J Inflamm Res"},{"key":"2934_CR55","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1523\/JNEUROSCI.0131-20.2020","volume":"40","author":"CM Freria","year":"2020","unstructured":"Freria CM, Brennan FH, Sweet DR, Guan Z, Hall JC, Kigerl KA, Nemeth DP, Liu X, Lacroix S, Quan N, Popovich PG. Serial systemic injections of endotoxin (LPS) elicit neuroprotective spinal cord microglia through IL-1-dependent cross talk with endothelial cells. J Neurosci. 2020;40:9103\u201320.","journal-title":"J Neurosci"},{"key":"2934_CR56","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1021\/acschemneuro.8b00511","volume":"10","author":"GA Prieto","year":"2019","unstructured":"Prieto GA, Smith ED, Tong L, Nguyen M, Cotman CW. Inhibition of LTP-induced translation by IL-1beta reduces the level of newly synthesized proteins in hippocampal dendrites. ACS Chem Neurosci. 2019;10:1197\u2013203.","journal-title":"ACS Chem Neurosci"},{"key":"2934_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12974-018-1158-9","volume":"15","author":"L Tong","year":"2018","unstructured":"Tong L, Prieto GA, Cotman CW. IL-1beta suppresses cLTP-induced surface expression of GluA1 and actin polymerization via ceramide-mediated Src activation. J Neuroinflamm. 2018;15:127.","journal-title":"J Neuroinflamm"},{"key":"2934_CR58","doi-asserted-by":"publisher","first-page":"E5078","DOI":"10.1073\/pnas.1514486112","volume":"112","author":"GA Prieto","year":"2015","unstructured":"Prieto GA, Snigdha S, Baglietto-Vargas D, Smith ED, Berchtold NC, Tong L, Ajami D, LaFerla FM, Rebek J Jr, Cotman CW. Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1beta in the aged hippocampus. Proc Natl Acad Sci U S A. 2015;112:E5078-5087.","journal-title":"Proc Natl Acad Sci U S A"}],"updated-by":[{"DOI":"10.1186\/s12974-023-02967-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000}}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02934-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T03:06:10Z","timestamp":1701399970000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02934-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2934"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02934-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12974-023-02967-8","URL":"https:\/\/doi.org\/10.1186\/s12974-023-02967-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the NIH's guidelines for laboratory animal care and received approval from the University of Kentucky's Institutional Animal Care and Use Committee (protocol no. 2017-2664).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}